nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisplatin—MPO—Propylthiouracil—Graves' disease	0.666	0.803	CbGbCtD
Cisplatin—CYP2B6—Methimazole—Graves' disease	0.107	0.129	CbGbCtD
Cisplatin—CYP2C9—Methimazole—Graves' disease	0.0566	0.0681	CbGbCtD
Cisplatin—Ageusia—Methimazole—Graves' disease	0.00397	0.104	CcSEcCtD
Cisplatin—MT1A—connective tissue—Graves' disease	0.00396	0.0407	CbGeAlD
Cisplatin—MT2A—eye—Graves' disease	0.00343	0.0352	CbGeAlD
Cisplatin—Ageusia—Propylthiouracil—Graves' disease	0.00338	0.0884	CcSEcCtD
Cisplatin—MT2A—connective tissue—Graves' disease	0.0033	0.0339	CbGeAlD
Cisplatin—Liver injury—Propylthiouracil—Graves' disease	0.00325	0.0851	CcSEcCtD
Cisplatin—MT1A—adipose tissue—Graves' disease	0.00304	0.0312	CbGeAlD
Cisplatin—ATP7A—connective tissue—Graves' disease	0.00286	0.0294	CbGeAlD
Cisplatin—ATP7B—pituitary gland—Graves' disease	0.00274	0.0281	CbGeAlD
Cisplatin—ATP7B—adipose tissue—Graves' disease	0.00272	0.028	CbGeAlD
Cisplatin—ABCC6—eye—Graves' disease	0.00272	0.028	CbGeAlD
Cisplatin—MT1A—thyroid gland—Graves' disease	0.00263	0.027	CbGeAlD
Cisplatin—ABCC6—connective tissue—Graves' disease	0.00262	0.0269	CbGeAlD
Cisplatin—MT2A—adipose tissue—Graves' disease	0.00253	0.026	CbGeAlD
Cisplatin—SLC31A2—pituitary gland—Graves' disease	0.0025	0.0257	CbGeAlD
Cisplatin—SLC31A2—adipose tissue—Graves' disease	0.00249	0.0256	CbGeAlD
Cisplatin—GSTM1—connective tissue—Graves' disease	0.00238	0.0244	CbGeAlD
Cisplatin—ATP7A—pituitary gland—Graves' disease	0.0022	0.0226	CbGeAlD
Cisplatin—ATP7A—adipose tissue—Graves' disease	0.00219	0.0225	CbGeAlD
Cisplatin—SLC31A2—thyroid gland—Graves' disease	0.00215	0.0221	CbGeAlD
Cisplatin—Renal failure acute—Propylthiouracil—Graves' disease	0.00215	0.0563	CcSEcCtD
Cisplatin—GSTT1—thyroid gland—Graves' disease	0.00215	0.022	CbGeAlD
Cisplatin—ABCC6—adipose tissue—Graves' disease	0.00201	0.0207	CbGeAlD
Cisplatin—SOD1—pituitary gland—Graves' disease	0.00193	0.0198	CbGeAlD
Cisplatin—SOD1—adipose tissue—Graves' disease	0.00192	0.0197	CbGeAlD
Cisplatin—ATP7A—thyroid gland—Graves' disease	0.0019	0.0195	CbGeAlD
Cisplatin—SLC31A1—pituitary gland—Graves' disease	0.00188	0.0193	CbGeAlD
Cisplatin—SLC31A1—adipose tissue—Graves' disease	0.00187	0.0192	CbGeAlD
Cisplatin—GSTM1—adipose tissue—Graves' disease	0.00183	0.0188	CbGeAlD
Cisplatin—Neuropathy peripheral—Methimazole—Graves' disease	0.00176	0.0462	CcSEcCtD
Cisplatin—ABCC6—thyroid gland—Graves' disease	0.00174	0.0179	CbGeAlD
Cisplatin—NQO1—eye—Graves' disease	0.00173	0.0178	CbGeAlD
Cisplatin—NQO1—connective tissue—Graves' disease	0.00167	0.0171	CbGeAlD
Cisplatin—SOD1—thyroid gland—Graves' disease	0.00166	0.0171	CbGeAlD
Cisplatin—SLC31A1—thyroid gland—Graves' disease	0.00162	0.0166	CbGeAlD
Cisplatin—GSTM1—thyroid gland—Graves' disease	0.00158	0.0162	CbGeAlD
Cisplatin—GSTP1—eye—Graves' disease	0.00155	0.0159	CbGeAlD
Cisplatin—MPO—connective tissue—Graves' disease	0.00153	0.0158	CbGeAlD
Cisplatin—Neuropathy peripheral—Propylthiouracil—Graves' disease	0.0015	0.0393	CcSEcCtD
Cisplatin—GSTP1—connective tissue—Graves' disease	0.00149	0.0153	CbGeAlD
Cisplatin—Alopecia—Methimazole—Graves' disease	0.00143	0.0374	CcSEcCtD
Cisplatin—ABCC5—pituitary gland—Graves' disease	0.00137	0.0141	CbGeAlD
Cisplatin—ABCC5—adipose tissue—Graves' disease	0.00137	0.0141	CbGeAlD
Cisplatin—NQO1—pituitary gland—Graves' disease	0.00128	0.0132	CbGeAlD
Cisplatin—NQO1—adipose tissue—Graves' disease	0.00128	0.0131	CbGeAlD
Cisplatin—Leukopenia—Methimazole—Graves' disease	0.00126	0.0329	CcSEcCtD
Cisplatin—ATP7B—Ion channel transport—GABRA3—Graves' disease	0.00125	0.0368	CbGpPWpGaD
Cisplatin—Alopecia—Propylthiouracil—Graves' disease	0.00121	0.0318	CcSEcCtD
Cisplatin—Myalgia—Methimazole—Graves' disease	0.0012	0.0313	CcSEcCtD
Cisplatin—ABCC5—thyroid gland—Graves' disease	0.00118	0.0122	CbGeAlD
Cisplatin—MPO—pituitary gland—Graves' disease	0.00118	0.0121	CbGeAlD
Cisplatin—ABCC3—adipose tissue—Graves' disease	0.00115	0.0118	CbGeAlD
Cisplatin—Oedema—Methimazole—Graves' disease	0.00115	0.03	CcSEcCtD
Cisplatin—GSTP1—pituitary gland—Graves' disease	0.00115	0.0118	CbGeAlD
Cisplatin—GSTP1—adipose tissue—Graves' disease	0.00114	0.0117	CbGeAlD
Cisplatin—Thrombocytopenia—Methimazole—Graves' disease	0.00112	0.0294	CcSEcCtD
Cisplatin—NQO1—thyroid gland—Graves' disease	0.00111	0.0114	CbGeAlD
Cisplatin—Leukopenia—Propylthiouracil—Graves' disease	0.00107	0.028	CcSEcCtD
Cisplatin—ATP7A—Ion channel transport—GABRA3—Graves' disease	0.00107	0.0313	CbGpPWpGaD
Cisplatin—Musculoskeletal discomfort—Methimazole—Graves' disease	0.00105	0.0274	CcSEcCtD
Cisplatin—Paraesthesia—Methimazole—Graves' disease	0.00103	0.027	CcSEcCtD
Cisplatin—Myalgia—Propylthiouracil—Graves' disease	0.00102	0.0266	CcSEcCtD
Cisplatin—ABCC3—thyroid gland—Graves' disease	0.000994	0.0102	CbGeAlD
Cisplatin—MT2A—Interferon gamma signaling—HLA-E—Graves' disease	0.000991	0.0291	CbGpPWpGaD
Cisplatin—GSTP1—thyroid gland—Graves' disease	0.00099	0.0102	CbGeAlD
Cisplatin—Oedema—Propylthiouracil—Graves' disease	0.000976	0.0255	CcSEcCtD
Cisplatin—Thrombocytopenia—Propylthiouracil—Graves' disease	0.000956	0.025	CcSEcCtD
Cisplatin—Body temperature increased—Methimazole—Graves' disease	0.000908	0.0237	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Propylthiouracil—Graves' disease	0.000889	0.0233	CcSEcCtD
Cisplatin—Paraesthesia—Propylthiouracil—Graves' disease	0.000877	0.0229	CcSEcCtD
Cisplatin—MT2A—Interferon gamma signaling—HLA-DQB1—Graves' disease	0.000786	0.0231	CbGpPWpGaD
Cisplatin—Body temperature increased—Propylthiouracil—Graves' disease	0.000772	0.0202	CcSEcCtD
Cisplatin—Vomiting—Methimazole—Graves' disease	0.00073	0.0191	CcSEcCtD
Cisplatin—Rash—Methimazole—Graves' disease	0.000724	0.0189	CcSEcCtD
Cisplatin—Dermatitis—Methimazole—Graves' disease	0.000723	0.0189	CcSEcCtD
Cisplatin—MT2A—Interferon gamma signaling—HLA-B—Graves' disease	0.000706	0.0207	CbGpPWpGaD
Cisplatin—PTGS2—connective tissue—Graves' disease	0.000695	0.00714	CbGeAlD
Cisplatin—BCHE—pituitary gland—Graves' disease	0.000695	0.00714	CbGeAlD
Cisplatin—BCHE—adipose tissue—Graves' disease	0.000692	0.00711	CbGeAlD
Cisplatin—Nausea—Methimazole—Graves' disease	0.000682	0.0178	CcSEcCtD
Cisplatin—ABCG2—pituitary gland—Graves' disease	0.000672	0.0069	CbGeAlD
Cisplatin—ABCG2—adipose tissue—Graves' disease	0.000669	0.00687	CbGeAlD
Cisplatin—MT2A—Interferon gamma signaling—HLA-A—Graves' disease	0.000654	0.0192	CbGpPWpGaD
Cisplatin—MT2A—AP-1 transcription factor network—HLA-A—Graves' disease	0.000647	0.019	CbGpPWpGaD
Cisplatin—Vomiting—Propylthiouracil—Graves' disease	0.000621	0.0162	CcSEcCtD
Cisplatin—Rash—Propylthiouracil—Graves' disease	0.000616	0.0161	CcSEcCtD
Cisplatin—Dermatitis—Propylthiouracil—Graves' disease	0.000615	0.0161	CcSEcCtD
Cisplatin—BCHE—thyroid gland—Graves' disease	0.000599	0.00616	CbGeAlD
Cisplatin—MT2A—Interferon gamma signaling—HLA-DRB1—Graves' disease	0.000598	0.0175	CbGpPWpGaD
Cisplatin—Nausea—Propylthiouracil—Graves' disease	0.00058	0.0152	CcSEcCtD
Cisplatin—ABCG2—thyroid gland—Graves' disease	0.000579	0.00595	CbGeAlD
Cisplatin—MT2A—Interferon gamma signaling—ICAM1—Graves' disease	0.000574	0.0168	CbGpPWpGaD
Cisplatin—PTGS2—pituitary gland—Graves' disease	0.000536	0.0055	CbGeAlD
Cisplatin—PTGS2—adipose tissue—Graves' disease	0.000533	0.00548	CbGeAlD
Cisplatin—ABCC5—Defective B3GAT3 causes JDSSDHD—B3GNT2—Graves' disease	0.000489	0.0144	CbGpPWpGaD
Cisplatin—MT2A—Interferon Signaling—HLA-E—Graves' disease	0.000484	0.0142	CbGpPWpGaD
Cisplatin—SOD1—Vitamin B12 Metabolism—ICAM1—Graves' disease	0.000468	0.0137	CbGpPWpGaD
Cisplatin—NQO1—Validated transcriptional targets of TAp63 isoforms—FAS—Graves' disease	0.000441	0.0129	CbGpPWpGaD
Cisplatin—MT2A—Interferon gamma signaling—IFNG—Graves' disease	0.000437	0.0128	CbGpPWpGaD
Cisplatin—ATP7B—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000436	0.0128	CbGpPWpGaD
Cisplatin—MT2A—AP-1 transcription factor network—IFNG—Graves' disease	0.000432	0.0127	CbGpPWpGaD
Cisplatin—MPO—Vitamin B12 Metabolism—ICAM1—Graves' disease	0.000408	0.012	CbGpPWpGaD
Cisplatin—MPO—IL23-mediated signaling events—IFNG—Graves' disease	0.000402	0.0118	CbGpPWpGaD
Cisplatin—MPO—IL23-mediated signaling events—CD4—Graves' disease	0.000388	0.0114	CbGpPWpGaD
Cisplatin—MT2A—Interferon Signaling—HLA-DQB1—Graves' disease	0.000384	0.0113	CbGpPWpGaD
Cisplatin—SOD1—Folate Metabolism—ICAM1—Graves' disease	0.000381	0.0112	CbGpPWpGaD
Cisplatin—ATP7A—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000371	0.0109	CbGpPWpGaD
Cisplatin—MPO—IL23-mediated signaling events—IL1B—Graves' disease	0.000358	0.0105	CbGpPWpGaD
Cisplatin—SOD1—Vitamin B12 Metabolism—IFNG—Graves' disease	0.000356	0.0104	CbGpPWpGaD
Cisplatin—ABCC6—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000356	0.0104	CbGpPWpGaD
Cisplatin—SLC31A1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000356	0.0104	CbGpPWpGaD
Cisplatin—MT2A—Interferon Signaling—HLA-B—Graves' disease	0.000345	0.0101	CbGpPWpGaD
Cisplatin—MPO—Folate Metabolism—ICAM1—Graves' disease	0.000332	0.00974	CbGpPWpGaD
Cisplatin—ABCB1—pituitary gland—Graves' disease	0.000331	0.0034	CbGeAlD
Cisplatin—ABCB1—adipose tissue—Graves' disease	0.00033	0.00339	CbGeAlD
Cisplatin—NQO1—Aryl Hydrocarbon Receptor Pathway—IFNG—Graves' disease	0.000329	0.00964	CbGpPWpGaD
Cisplatin—MT2A—Cytokine Signaling in Immune system—HLA-E—Graves' disease	0.000323	0.00948	CbGpPWpGaD
Cisplatin—MT2A—Interferon Signaling—HLA-A—Graves' disease	0.00032	0.00937	CbGpPWpGaD
Cisplatin—SOD1—Vitamin B12 Metabolism—IL1B—Graves' disease	0.000318	0.00931	CbGpPWpGaD
Cisplatin—MPO—Vitamin B12 Metabolism—IFNG—Graves' disease	0.000311	0.00911	CbGpPWpGaD
Cisplatin—SOD1—Selenium Micronutrient Network—ICAM1—Graves' disease	0.000302	0.00887	CbGpPWpGaD
Cisplatin—NQO1—Aryl Hydrocarbon Receptor Pathway—IL1B—Graves' disease	0.000293	0.0086	CbGpPWpGaD
Cisplatin—MT2A—Interferon Signaling—HLA-DRB1—Graves' disease	0.000292	0.00856	CbGpPWpGaD
Cisplatin—SOD1—Amyotrophic lateral sclerosis (ALS)—TNF—Graves' disease	0.000292	0.00855	CbGpPWpGaD
Cisplatin—SOD1—Folate Metabolism—IFNG—Graves' disease	0.00029	0.0085	CbGpPWpGaD
Cisplatin—ABCB1—thyroid gland—Graves' disease	0.000286	0.00293	CbGeAlD
Cisplatin—MT2A—Interferon Signaling—ICAM1—Graves' disease	0.00028	0.00822	CbGpPWpGaD
Cisplatin—MPO—Vitamin B12 Metabolism—IL1B—Graves' disease	0.000277	0.00813	CbGpPWpGaD
Cisplatin—MPO—Selenium Micronutrient Network—ICAM1—Graves' disease	0.000264	0.00774	CbGpPWpGaD
Cisplatin—ABCC5—Carbohydrate metabolism—B3GNT2—Graves' disease	0.000263	0.00771	CbGpPWpGaD
Cisplatin—MPO—IL23-mediated signaling events—TNF—Graves' disease	0.00026	0.00762	CbGpPWpGaD
Cisplatin—SOD1—Folate Metabolism—IL1B—Graves' disease	0.000258	0.00758	CbGpPWpGaD
Cisplatin—MT2A—Cytokine Signaling in Immune system—HLA-DQB1—Graves' disease	0.000256	0.00752	CbGpPWpGaD
Cisplatin—MPO—Folate Metabolism—IFNG—Graves' disease	0.000253	0.00741	CbGpPWpGaD
Cisplatin—PTGS2—Calcium signaling in the CD4+ TCR pathway—FASLG—Graves' disease	0.000251	0.00735	CbGpPWpGaD
Cisplatin—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2RA—Graves' disease	0.00024	0.00705	CbGpPWpGaD
Cisplatin—GSTM1—C-MYB transcription factor network—CD4—Graves' disease	0.000237	0.00694	CbGpPWpGaD
Cisplatin—XDH—Selenium Micronutrient Network—ICAM1—Graves' disease	0.000231	0.00676	CbGpPWpGaD
Cisplatin—SOD1—Vitamin B12 Metabolism—TNF—Graves' disease	0.00023	0.00676	CbGpPWpGaD
Cisplatin—MT2A—Cytokine Signaling in Immune system—HLA-B—Graves' disease	0.00023	0.00675	CbGpPWpGaD
Cisplatin—SOD1—Selenium Micronutrient Network—IFNG—Graves' disease	0.00023	0.00675	CbGpPWpGaD
Cisplatin—MPO—Folate Metabolism—IL1B—Graves' disease	0.000225	0.00661	CbGpPWpGaD
Cisplatin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—Graves' disease	0.000224	0.00658	CbGpPWpGaD
Cisplatin—BCHE—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000223	0.00655	CbGpPWpGaD
Cisplatin—MT2A—Cytokine Signaling in Immune system—IL2RA—Graves' disease	0.000216	0.00633	CbGpPWpGaD
Cisplatin—MT2A—Cytokine Signaling in Immune system—HLA-A—Graves' disease	0.000213	0.00626	CbGpPWpGaD
Cisplatin—MT2A—Interferon Signaling—IFNG—Graves' disease	0.000213	0.00625	CbGpPWpGaD
Cisplatin—NQO1—Aryl Hydrocarbon Receptor Pathway—TNF—Graves' disease	0.000213	0.00624	CbGpPWpGaD
Cisplatin—NQO1—Aryl Hydrocarbon Receptor—TNF—Graves' disease	0.000213	0.00624	CbGpPWpGaD
Cisplatin—SOD1—Selenium Micronutrient Network—IL1B—Graves' disease	0.000205	0.00602	CbGpPWpGaD
Cisplatin—MPO—C-MYB transcription factor network—CD4—Graves' disease	0.000201	0.0059	CbGpPWpGaD
Cisplatin—MPO—Vitamin B12 Metabolism—TNF—Graves' disease	0.000201	0.0059	CbGpPWpGaD
Cisplatin—MPO—Selenium Micronutrient Network—IFNG—Graves' disease	0.000201	0.00589	CbGpPWpGaD
Cisplatin—SLC22A2—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000199	0.00585	CbGpPWpGaD
Cisplatin—MT2A—Cytokine Signaling in Immune system—HLA-DRB1—Graves' disease	0.000195	0.00572	CbGpPWpGaD
Cisplatin—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—Graves' disease	0.00019	0.00557	CbGpPWpGaD
Cisplatin—SOD1—Folate Metabolism—TNF—Graves' disease	0.000187	0.0055	CbGpPWpGaD
Cisplatin—MT2A—Cytokine Signaling in Immune system—ICAM1—Graves' disease	0.000187	0.00549	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—GC—Graves' disease	0.000179	0.00525	CbGpPWpGaD
Cisplatin—MPO—Selenium Micronutrient Network—IL1B—Graves' disease	0.000179	0.00525	CbGpPWpGaD
Cisplatin—XDH—Selenium Micronutrient Network—IFNG—Graves' disease	0.000175	0.00515	CbGpPWpGaD
Cisplatin—BCHE—Neuronal System—GABRA3—Graves' disease	0.000171	0.00502	CbGpPWpGaD
Cisplatin—SOD1—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	0.000167	0.0049	CbGpPWpGaD
Cisplatin—MPO—Folate Metabolism—TNF—Graves' disease	0.000164	0.0048	CbGpPWpGaD
Cisplatin—ABCC5—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000163	0.00479	CbGpPWpGaD
Cisplatin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—Graves' disease	0.000162	0.00475	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.00016	0.0047	CbGpPWpGaD
Cisplatin—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—Graves' disease	0.000159	0.00465	CbGpPWpGaD
Cisplatin—XDH—Selenium Micronutrient Network—IL1B—Graves' disease	0.000157	0.00459	CbGpPWpGaD
Cisplatin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—Graves' disease	0.000155	0.00456	CbGpPWpGaD
Cisplatin—SLC22A2—Neuronal System—GABRA3—Graves' disease	0.000153	0.00448	CbGpPWpGaD
Cisplatin—SOD1—Selenium Micronutrient Network—TNF—Graves' disease	0.000149	0.00437	CbGpPWpGaD
Cisplatin—PTGS2—Overview of nanoparticle effects—TNF—Graves' disease	0.000144	0.00422	CbGpPWpGaD
Cisplatin—MT2A—Cytokine Signaling in Immune system—IFNG—Graves' disease	0.000142	0.00418	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000136	0.00399	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—B3GNT2—Graves' disease	0.000136	0.00398	CbGpPWpGaD
Cisplatin—MT2A—Immune System—IFIH1—Graves' disease	0.000134	0.00393	CbGpPWpGaD
Cisplatin—MPO—Selenium Micronutrient Network—TNF—Graves' disease	0.00013	0.00381	CbGpPWpGaD
Cisplatin—MT2A—Cytokine Signaling in Immune system—IL1B—Graves' disease	0.000127	0.00372	CbGpPWpGaD
Cisplatin—ABCC3—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.00012	0.00353	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—GC—Graves' disease	0.000115	0.00339	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—HLA-E—Graves' disease	0.000114	0.00336	CbGpPWpGaD
Cisplatin—XDH—Selenium Micronutrient Network—TNF—Graves' disease	0.000114	0.00333	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—CD40—Graves' disease	0.000112	0.00328	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—CTLA4—Graves' disease	0.00011	0.00323	CbGpPWpGaD
Cisplatin—MT2A—Immune System—HLA-E—Graves' disease	0.000106	0.0031	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000104	0.00305	CbGpPWpGaD
Cisplatin—MT2A—Immune System—CD40—Graves' disease	0.000103	0.00303	CbGpPWpGaD
Cisplatin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—Graves' disease	0.000103	0.00301	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—CXCL10—Graves' disease	0.000102	0.003	CbGpPWpGaD
Cisplatin—MT2A—Immune System—CTLA4—Graves' disease	0.000102	0.00298	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—GC—Graves' disease	9.82e-05	0.00288	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—GC—Graves' disease	9.57e-05	0.00281	CbGpPWpGaD
Cisplatin—ABCC2—Transmembrane transport of small molecules—GABRA3—Graves' disease	9.54e-05	0.0028	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—HLA-DQB1—Graves' disease	9.08e-05	0.00266	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—B3GNT2—Graves' disease	8.75e-05	0.00257	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—IL2RA—Graves' disease	8.61e-05	0.00252	CbGpPWpGaD
Cisplatin—XDH—Metabolism—GC—Graves' disease	8.58e-05	0.00252	CbGpPWpGaD
Cisplatin—PTGS2—Selenium Micronutrient Network—ICAM1—Graves' disease	8.57e-05	0.00251	CbGpPWpGaD
Cisplatin—MT2A—Immune System—HLA-DQB1—Graves' disease	8.37e-05	0.00246	CbGpPWpGaD
Cisplatin—ABCG2—Transmembrane transport of small molecules—GABRA3—Graves' disease	8.3e-05	0.00243	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—GC—Graves' disease	8.23e-05	0.00241	CbGpPWpGaD
Cisplatin—SLC22A2—Transmembrane transport of small molecules—GABRA3—Graves' disease	8.21e-05	0.00241	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—HLA-B—Graves' disease	8.15e-05	0.00239	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—FASLG—Graves' disease	7.97e-05	0.00234	CbGpPWpGaD
Cisplatin—MT2A—Immune System—CD8A—Graves' disease	7.82e-05	0.00229	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—FAS—Graves' disease	7.68e-05	0.00225	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—IL2RA—Graves' disease	7.64e-05	0.00224	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—HLA-A—Graves' disease	7.55e-05	0.00222	CbGpPWpGaD
Cisplatin—MT2A—Immune System—HLA-B—Graves' disease	7.52e-05	0.00221	CbGpPWpGaD
Cisplatin—ABCC5—Disease—B3GNT2—Graves' disease	7.44e-05	0.00218	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—B3GNT2—Graves' disease	7.44e-05	0.00218	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—B3GNT2—Graves' disease	7.25e-05	0.00213	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—GC—Graves' disease	7.16e-05	0.0021	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—GC—Graves' disease	7.13e-05	0.00209	CbGpPWpGaD
Cisplatin—PTGS2—Aryl Hydrocarbon Receptor—TNF—Graves' disease	7.09e-05	0.00208	CbGpPWpGaD
Cisplatin—MT2A—Immune System—IL2RA—Graves' disease	7.05e-05	0.00207	CbGpPWpGaD
Cisplatin—MT2A—Immune System—HLA-A—Graves' disease	6.97e-05	0.00204	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—HLA-DRB1—Graves' disease	6.9e-05	0.00202	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—B3GNT2—Graves' disease	6.81e-05	0.002	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—ICAM1—Graves' disease	6.78e-05	0.00199	CbGpPWpGaD
Cisplatin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Graves' disease	6.64e-05	0.00195	CbGpPWpGaD
Cisplatin—PTGS2—C-MYB transcription factor network—CD4—Graves' disease	6.54e-05	0.00192	CbGpPWpGaD
Cisplatin—PTGS2—Selenium Micronutrient Network—IFNG—Graves' disease	6.52e-05	0.00191	CbGpPWpGaD
Cisplatin—XDH—Metabolism—B3GNT2—Graves' disease	6.5e-05	0.00191	CbGpPWpGaD
Cisplatin—MT2A—Immune System—HLA-DRB1—Graves' disease	6.37e-05	0.00187	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—B3GNT2—Graves' disease	6.23e-05	0.00183	CbGpPWpGaD
Cisplatin—MT2A—Immune System—ICAM1—Graves' disease	6.11e-05	0.00179	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—GC—Graves' disease	6.06e-05	0.00178	CbGpPWpGaD
Cisplatin—PTGS2—Selenium Micronutrient Network—IL1B—Graves' disease	5.82e-05	0.00171	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—Graves' disease	5.55e-05	0.00163	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—B3GNT2—Graves' disease	5.41e-05	0.00159	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—Graves' disease	5.35e-05	0.00157	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—IFNG—Graves' disease	5.16e-05	0.00151	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—IFNG—Graves' disease	5.04e-05	0.00148	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—GC—Graves' disease	4.74e-05	0.00139	CbGpPWpGaD
Cisplatin—MT2A—Immune System—IFNG—Graves' disease	4.65e-05	0.00136	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—GC—Graves' disease	4.63e-05	0.00136	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—IL1B—Graves' disease	4.6e-05	0.00135	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—B3GNT2—Graves' disease	4.6e-05	0.00135	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—IL1B—Graves' disease	4.5e-05	0.00132	CbGpPWpGaD
Cisplatin—MT2A—Immune System—CD4—Graves' disease	4.49e-05	0.00132	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—GABRA3—Graves' disease	4.49e-05	0.00132	CbGpPWpGaD
Cisplatin—PTGS2—Selenium Micronutrient Network—TNF—Graves' disease	4.22e-05	0.00124	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—GC—Graves' disease	4.18e-05	0.00123	CbGpPWpGaD
Cisplatin—MT2A—Immune System—IL1B—Graves' disease	4.15e-05	0.00122	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—GC—Graves' disease	4.14e-05	0.00121	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—Graves' disease	3.93e-05	0.00115	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—Graves' disease	3.79e-05	0.00111	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—B3GNT2—Graves' disease	3.51e-05	0.00103	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—TNF—Graves' disease	3.34e-05	0.000979	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—TNF—Graves' disease	3.26e-05	0.000957	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—GC—Graves' disease	3.19e-05	0.000935	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—B3GNT2—Graves' disease	3.17e-05	0.000929	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—B3GNT2—Graves' disease	3.14e-05	0.00092	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—GC—Graves' disease	3.06e-05	0.000899	CbGpPWpGaD
Cisplatin—ABCC5—Disease—HLA-A—Graves' disease	3.01e-05	0.000883	CbGpPWpGaD
Cisplatin—PTGS2—Disease—B3GNT2—Graves' disease	2.89e-05	0.000846	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—B3GNT2—Graves' disease	2.42e-05	0.000709	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—B3GNT2—Graves' disease	2.32e-05	0.000681	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	2.27e-05	0.000666	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GC—Graves' disease	2.26e-05	0.000663	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GC—Graves' disease	2.11e-05	0.000619	CbGpPWpGaD
Cisplatin—ABCC5—Disease—CD4—Graves' disease	1.94e-05	0.000569	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—B3GNT2—Graves' disease	1.71e-05	0.000502	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	1.61e-05	0.000472	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—B3GNT2—Graves' disease	1.6e-05	0.000469	CbGpPWpGaD
Cisplatin—PTGS2—Disease—HLA-A—Graves' disease	1.17e-05	0.000343	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CD4—Graves' disease	7.53e-06	0.000221	CbGpPWpGaD
